Meyka AI API is live for developers.Start building.
Advertisement
SI-BONE, Inc.

SI-BONE, Inc. (SIBN) Stock Overview

Explore SI-BONE, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SIBNNASDAQ
HealthcareMedical - Devices
$15.12
$0.24(1.61%)
U.S. Market opens in 54h 21m
Advertisement

SI-BONE, Inc. (SIBN)

Meyka AI Score

Z

Key Financials

Market Cap670.6M
P/E Ratio-39.39
EPS (TTM)$-0.39
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$13.23
3 Months$17.77
1 Year Target$14.82

SIBN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SI-BONE, Inc. (SIBN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.82.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -39.39 and a market capitalization of 670.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.61%
5-Day Change
4.64%
1-Month Change
11.59%
3-Month Change
7.46%
6-Month Change
-23.17%
Year-to-Date (YTD) Change
-23.33%
1-Year Change
-20.67%
3-Year Change
-43.71%
5-Year Change
-51.72%
All-Time (Max) Change
-24.63%

Contact Information

408 207 0700
471 El Camino Real, Santa Clara, CA, 95050

Company Facts

349 Employees
IPO DateOct 17, 2018
CountryUS
Actively Trading

Frequently Asked Questions